University of Dundee, Takeda partner on tau pathologies

The Drug Discovery Unit of the University of Dundee (Dundee, U.K.) partnered with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to develop small molecules that prevent the spread tau pathology from diseased to healthy cells to treat tauopathies such as Alzheimer's disease...